恆康醫療(002219.SZ)擬出售恆康醫療投資(澳大利亞)100%股權
格隆匯11月5日丨恆康醫療(002219.SZ)公佈,公司擬出售澳大利亞全資子公司恆康醫療投資(澳大利亞)有限責任公司(“標的公司”)100%的股權。標的公司持有PRP Diagnostic Imaging Holdings Limited(“PRP公司”)70.33%的股權。《股權轉讓協議》顯示,此次股權出售對價為1000萬澳元[人民幣4841.70萬元]。
為了緩解公司資金壓力,補充公司資金流動性,公司決定出售標的公司股權。此次股權轉讓符合公司目前實際經營情況,有利於降低公司經營風險,減少財務費用的支出,降低管理成本,有效保障公司長遠健康穩定發展,不會損害中小股東和投資者利益。此次交易交割完成後,公司將減少借款(審計報告賬面)12.159億元,預計每年節約財務費用約1.45億元。
此次股權轉讓完成後,公司將不再持有標的公司的股權,標的公司將不再納入公司合併報表範圍,此次交易將對當期淨利潤影響約為-4.78億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.